Cidara Therapeutics Inc. Com New
13F holders, Q3 2025 (September 30)5holders +3
4new positions
1sold out
$95.73avg. 13F price*
At the end of Q3 2025, 5 institutions reported holding Cidara Therapeutics Inc. Com New in their 13F filings, up 3 from Q2 2025. 4 opened new positions and 1 sold out. The largest holders were Jeppson Wealth Management, LLC ($589K), Thoroughbred Financial Services, LLC ($472K) and LRI Investments, LLC ($5K).
- Company
- Cidara Therapeutics Inc. Com New
- CUSIP
- 171757107
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $479K |
| Exits | 1 | $62 |
All 13F filers, Q2 2025 → Q3 2025: 5,007 shares bought and 1 shares sold, net +5,006 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Jeppson Wealth Management, LLC | 0.19% | No change | 6,155 | $589K |
| Thoroughbred Financial Services, LLC | 0.03% | New | 4,932 | $472K |
| LRI Investments, LLC | 0.00% | New | 55 | $5K |
| Rothschild Investment LLC | 0.00% | New | 15 | $1K |
| Farther Finance Advisors, LLC | 0.00% | New | 5 | $479 |
"% of holder's portfolio" is CIDARA THERAPEUTICS INC COM NEW's weight in each manager's 13F, not the share of Cidara Therapeutics Inc. Com New the manager owns.